Mancini Anthony sold RVMD
September 16, 2026 · Form 4 insider transaction
Mancini Anthony sold 27 shares of Revolution Medicines, Inc. at $195.05 per share, a transaction worth $5.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on June 15, 2026 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.; The transaction was executed in multiple trades at prices ranging from $195.03 to $195.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.